AllianceBernstein’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Hold |
144,830
| – | – | ﹤0.01% | 2492 |
|
|
2025
Q1 | $795K | Buy |
144,830
+13,260
| +10% | +$72.8K | ﹤0.01% | 2349 |
|
|
2024
Q4 | $446K | Sell |
131,570
-16,150
| -11% | -$54.7K | ﹤0.01% | 2689 |
|
|
2024
Q3 | $421K | Hold |
147,720
| – | – | ﹤0.01% | 2750 |
|
|
2024
Q2 | $332K | Buy |
147,720
+67,300
| +84% | +$151K | ﹤0.01% | 2876 |
|
|
2024
Q1 | $178K | Hold |
80,420
| – | – | ﹤0.01% | 2948 |
|
|
2023
Q4 | $189K | Hold |
80,420
| – | – | ﹤0.01% | 2990 |
|
|
2023
Q3 | $150K | Buy |
80,420
+9,970
| +14% | +$18.5K | ﹤0.01% | 3009 |
|
|
2023
Q2 | $185K | Buy |
70,450
+31,050
| +79% | +$81.4K | ﹤0.01% | 3000 |
|
|
2023
Q1 | $64.2K | Hold |
39,400
| – | – | ﹤0.01% | 3073 |
|
|
2022
Q4 | $52.4K | Buy |
39,400
+15,300
| +63% | +$20.3K | ﹤0.01% | 3170 |
|
|
2022
Q3 | $38K | Buy |
24,100
+10,300
| +75% | +$16.2K | ﹤0.01% | 3189 |
|
|
2022
Q2 | $21K | Buy |
+13,800
| New | +$21K | ﹤0.01% | 3203 |
|
|
2021
Q2 | – | Sell |
-35,100
| Closed | -$158K | – | 3407 |
|
|
2021
Q1 | $158K | Hold |
35,100
| – | – | ﹤0.01% | 3090 |
|
|
2020
Q4 | $173K | Hold |
35,100
| – | – | ﹤0.01% | 3017 |
|
|
2020
Q3 | $208K | Hold |
35,100
| – | – | ﹤0.01% | 2945 |
|
|
2020
Q2 | $93K | Buy |
35,100
+14,600
| +71% | +$38.7K | ﹤0.01% | 3100 |
|
|
2020
Q1 | $40K | Hold |
20,500
| – | – | ﹤0.01% | 3067 |
|
|
2019
Q4 | $145K | Hold |
20,500
| – | – | ﹤0.01% | 2977 |
|
|
2019
Q3 | $202K | Buy |
20,500
+3,200
| +18% | +$31.5K | ﹤0.01% | 2932 |
|
|
2019
Q2 | $198K | Buy |
+17,300
| New | +$198K | ﹤0.01% | 2969 |
|